176 related articles for article (PubMed ID: 436537)
1. Treatment of arrhythmias in the Wolff-Parkinson-White syndrome.
Forester D
Chest; 1979 Jun; 75(6):745. PubMed ID: 436537
[No Abstract] [Full Text] [Related]
2. Lidocaine in Wolff-Parkinson-White syndrome with atrial fibrillation.
Josephson ME; Kastor JA; Kitchen JG
Ann Intern Med; 1976 Jan; 84(1):44-5. PubMed ID: 1244791
[TBL] [Abstract][Full Text] [Related]
3. Disopyramide in patients with the Wolff-Parkinson-White syndrome and atrial fibrillation.
Bennett DH
Chest; 1978 Dec; 74(6):624-8. PubMed ID: 738119
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndrome.
Prystowsky EN
Herz; 1983 Jun; 8(3):133-43. PubMed ID: 6135656
[No Abstract] [Full Text] [Related]
5. Treatment of cardiac arrhythmias.
Robinson SJ
Pediatr Clin North Am; 1964 May; 11(2):315-62. PubMed ID: 4174540
[No Abstract] [Full Text] [Related]
6. Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome.
Sellers TD; Campbell RW; Bashore TM; Gallagher JJ
Circulation; 1977 Jan; 55(1):15-22. PubMed ID: 830205
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. A.
Hoffman BF; Rosen MR; Wit AL
Am Heart J; 1975 Jun; 89(6):804-8. PubMed ID: 1130271
[No Abstract] [Full Text] [Related]
8. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
Meltzer RS; Robert EW; McMorrow M; Martin RP
Am J Cardiol; 1978 Dec; 42(6):1049-53. PubMed ID: 727132
[TBL] [Abstract][Full Text] [Related]
9. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
[TBL] [Abstract][Full Text] [Related]
10. [Contraindications to the use of digitalis in atrial fibrillation in the course of Wolff-Parkinson-White syndrome].
Bracchetti D; Binetti G; D'Osualdo F; Magnani B
Boll Soc Ital Cardiol; 1974; 19(2):181-6. PubMed ID: 4462802
[No Abstract] [Full Text] [Related]
11. Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: technique, application, and efficacy in severely symptomatic preexcitation patients.
Bauernfeind RA; Swiryn SP; Strasberg B; Palileo E; Scagliotti D; Rosen KM
Am Heart J; 1982 Jun; 103(6):941-9. PubMed ID: 7081034
[TBL] [Abstract][Full Text] [Related]
12. Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome.
Spurrell RA; Thorburn CW; Camm J; Sowton E; Deuchar DC
Br Heart J; 1975 Aug; 37(8):861-7. PubMed ID: 53057
[TBL] [Abstract][Full Text] [Related]
13. Tachyarrhythmias in Wolff-Parkinson-White syndrome. Treatment and prevention.
Tonkin AM; Gallagher JJ; Wallace AG
JAMA; 1976 Mar; 235(9):947-9. PubMed ID: 946127
[No Abstract] [Full Text] [Related]
14. Treatment of ventricular tachycardia in an infant.
Sanchez J; Christie K; Cumming GR
Can Med Assoc J; 1972 Jul; 107(2):136-8. PubMed ID: 5041936
[No Abstract] [Full Text] [Related]
15. Electrophysiologic effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome.
Kerr CR; Prystowsky EN; Smith WM; Cook L; Gallagher JJ
Circulation; 1982 May; 65(5):869-78. PubMed ID: 6804107
[TBL] [Abstract][Full Text] [Related]
16. Disopyramide.
Morady F; Scheinman MM; Desai J
Ann Intern Med; 1982 Mar; 96(3):337-43. PubMed ID: 7036817
[TBL] [Abstract][Full Text] [Related]
17. Clinical studies of Norpace (Part X).
Dreifus LS
Angiology; 1975 Jan; 26(1 Pt 2):148. PubMed ID: 46728
[No Abstract] [Full Text] [Related]
18. Three therapeutic approaches in tachycardia.
Preston TA; Yates JD; Brymer JF
Geriatrics; 1973 Mar; 28(3):110-6. PubMed ID: 4691599
[No Abstract] [Full Text] [Related]
19. Ventricular fibrillation in Wolff-Parkinson-White syndrome, type A.
Papa LA; Saia JA; Chung EK
Heart Lung; 1978; 7(6):1015-9. PubMed ID: 251167
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of atrial fibrillation in patients with Wolff-Parkinson-White syndrome using ajmaline and quinidine].
García Civera R; Sanjuán Mañez R; Rodríguez Serra M; García-Sacritán J; Morell Cabedo S; Llavador Sanchis J
Rev Esp Cardiol; 1982; 35(3):277-84. PubMed ID: 7134591
[No Abstract] [Full Text] [Related]
[Next] [New Search]
